<DOC>
	<DOCNO>NCT01018472</DOCNO>
	<brief_summary>Infants congenital heart disease frequent infection exposure antibiotic healthy infant . It unknown congenital heart disease affect development bacterial colonization intestine . It also unknown whether probiotic change bacteria intestine infant heart disease become like healthy infant without heart disease . This pilot trial design address two question .</brief_summary>
	<brief_title>Probiotics Infants With Cyanotic Congenital Heart Disease</brief_title>
	<detailed_description>Infants cyanotic congenital heart disease randomly assign receive either placebo probiotic Bifidobacterium infantis . Comparisons make infant receive placebo healthy infant without heart disease infant receive placebo receive probiotic .</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Heart Defects , Congenital</mesh_term>
	<criteria>Cyanotic congenital heart disease Term infant Born transfer UC Davis Children 's hospital Congenital anomalies intestinal tract</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>4 Months</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>cyanotic heart disease</keyword>
	<keyword>congenital heart disease</keyword>
	<keyword>intestinal microbiota</keyword>
	<keyword>probiotic</keyword>
</DOC>